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The cowpea (Vigna unguiculata) line Arlington, inoculated with Cowpea mosaic virus (CPMV), showed no symptoms, and
no infectivity or accumulation of capsid antigen was detected at several days after inoculation. Coinoculation, but not
sequential inoculation, of CPMV with similar concentrations of another Comovirus; Cowpea severe mosaic virus (CPSMV),
resulted in reduced numbers of CPSMV-induced lesions. This apparent, CPMV-mediated reduction in number of CPSMV-
induced infection centers was termed concurrent protection. We report results obtained by inoculating two nearly isogenic
cowpea lines derived from a CPMV-susceptible cowpea crossed to Arlington, one line CPMV-susceptible and the other
resistant. The CPMV virions B and M, encapsidating genomic RNAs 1 and 2, respectively, were extensively purified by
gradient centrifugation. In the CPMV-resistant cowpea, either CPMV or CPMV B affected concurrent protection against
CPSMV and against two distinct non-Comoviruses: Cherry leafroll virus and Southern bean mosaic virus. Adding CPMV M to
the inoculum did not enhance CPMV-B-mediated protection. CPMV B was ineffective in protecting CPMV-susceptible
cowpea. We postulate that CPMV-mediated concurrent protection is elicited in CPMV-resistant cowpea by a CPMV
RNA-1-encoded factor and acts to reduce accumulation or spread of CPMV and certain coinoculated challenging viruses in
or from the inoculated cell. Coinoculated CPMV did not protect CPMV-resistant cowpea against Tomato bushy stunt virus or
Cucumber mosaic virus. © 2000 Academic Press
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1INTRODUCTION
Inoculation of the Comovirus Cowpea mosaic virus
(CPMV) to 1000 cowpea (Vigna unguiculata) lines re-
vealed that ;6% of the lines gave no detected symptoms,
and no infectivity or capsid antigen was recovered (Beier
et al., 1977). Line Arlington was selected from among the
6% because protoplasts from Arlington seedlings
showed reduced accumulation of CPMV capsid antigen,
virion RNA, RNA complementary to virion RNA, and in-
fectivity, relative to protoplasts from CPMV-susceptible
cowpea line Blackeye 5 (Beier et al., 1977, 1979; Bruening
and Kiefer, 1981; Eastwell et al., 1983). Arlington cowpea
eedlings resisted graft inoculation of CPMV (Beier et al.,
979). In crosses with line Blackeye 5, Arlington-derived
esistance of seedlings was inherited as a simple, dom-
nant locus (Kiefer et al., 1984; Saayer-Riep and de Jager,
988). As was observed for Arlington cowpea proto-
lasts, the CPMV titer in protoplasts from a F3 line
omozygous for resistance was reduced compared to
he titer in protoplasts from a CPMV-susceptible F3 line
erived from the same cross (Kiefer et al., 1984). Cowpea
rotoplasts from all of these sources were equally good
osts for another Comovirus (Swaans and van Kammen,
973; Chen and Bruening, 1992a,b), Cowpea severe mo-1 To whom reprint requests should be addressed. E-mail:
ebruening@ucdavis.edu.
29aic virus (CPSMV). Although line Arlington was selected
n the basis of reduced yield of CPMV, no evidence
irectly connects the robust resistance against CPMV
hown by Arlington cowpea seedlings to the reduced
PMV yield from protoplasts from Arlington or CPMV-
esistant F3 derivative of Arlington (Ponz and Bruening,
986; Ponz et al., 1988).
Coinoculation of CPMV and CPSMV at similar con-
centrations to primary leaves of Arlington cowpea
seedlings reduced the numbers of CPSMV-induced
lesions. CPMV RNA was similarly protective against
CPSMV, whereas coinoculated CPMV empty capsids
(top component) (Bruening, 1969) or ultraviolet-inacti-
vated CPMV RNA were not. Sequential inoculation of
CPMV and CPSMV reduced the degree of protection
compared to coinoculation (Bruening et al., 1979;
Bruening and Kiefer, 1981). Eastwell and Kalmar
(1997), using Arlington and CPMV-resistant line Black
(Beier et al., 1977), and Sterk and de Jager (1987),
using CPMV-resistant line Tvu470, obtained similar
results for CPMV and coinoculated CPSMV. Tvu470
and Black seedlings, although highly resistant to
CPMV, did not generate protoplasts showing reduced
yield of CPMV. Ponz and Bruening (1986) proposed the
term concurrent protection to describe a reduction in
challenging virus infection rate and/or titer due to
coinoculation with a protecting virus that does not
accumulate or induce symptoms in the host plant.
0042-6822/00 $35.00
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C300 BRUENING ET AL.CPMV-mediated concurrent protection was not dem-
onstrated using protoplasts as the host (Ponz and
Bruening, 1986).
We generated nearly isogenic cowpea lines, one ho-
mozygous for Arlington-derived resistance against
CPMV and the other susceptible. Our results with the
resistant and susceptible lines revealed CPMV-mediated
concurrent protection against CPSMV and two non-Co-
movirus challenging viruses and a close association of
concurrent protection with seedling resistance against
CPMV. We suggest a general mechanism for CPMV-
mediated concurrent protection that involves recognition
of CPMV by the CPMV-resistant plant and summarize the
evidence that distinguishes concurrent protection from
two other virus-interaction phenomena, cross protection
and acquired resistance.
RESULTS
Inoculum concentration dependence for CPMV-
mediated concurrent protection against CPSMV
Nearly isogenic cowpea lines were selected from the
progeny of an eight-stage backcross series initiated from
a Blackeye 5 3 Arlington cross with selection only for
resistance against CPMV. One line is homozygous for
resistance against CPMV. The other is a homozygous
CPMV-susceptible line. The distribution of resistant and
susceptible progeny derived from these crosses re-
mained consistent with the hypothesis that resistance is
specified by a single dominant locus. The CPMV-resis-
tant line, like the Arlington line (Beier et al., 1977, 1979),
showed no symptoms or accumulated virions or infectiv-
ity days after being inoculated with CPMV. The resis-
tance was observed for CPMV concentrations four or-
ders of magnitude greater (1 mg/ml vs 0.1 mg/ml) than a
dose that uniformly infected the nearly isogenic, suscep-
tible cowpea line (data not shown).
CPMV-mediated concurrent protection was tested
here with the CPMV-resistant line as host, in groups of
eight cowpea seedlings inoculated on opposite primary
leaves (Costa, 1944; Sterk and de Jager, 1987). One
primary leaf, designated the reference leaf, was inocu-
lated with CPSMV or other challenging virus alone. The
other, experimental, primary leaf was inoculated with a
mixture of CPMV and CPSMV or other challenging virus.
For each of the eight plants in a typical assay, we cal-
culated the ratio of experimental leaf lesion number to
the reference leaf lesion number and then the mean and
standard deviation for the eight ratios. To assess the
validity of the opposite leaf assay, some groups of CPMV-
resistant cowpea seedlings were inoculated with the
same concentration of challenging virus, alone, on both
the reference and experimental leaves. For eight sets of
seedlings inoculated with CPSMV (total of 64 seedlings),
the average of the means and the standard deviations
were 1.04 and 0.42, respectively. For eight sets of CPMV-
lresistant seedlings inoculated with Southern bean mo-
saic virus (SBMV), the corresponding values were 1.04
and 0.12 (64 seedlings). The work of Kleczkowski (1949)
may be considered for comparison. He inoculated pri-
mary leaves of sets of bean (Phaseolus vulgaris) seed-
lings with Tobacco necrosis virus (TNV). Half-leaf lesion
counts from a selected set appear in Table I of Klecz-
kowski (1949). Taking the data on a whole-leaf basis, the
mean and standard deviation for opposite-leaf lesion
number ratios, for 120 plants, are 1.08 and 0.37. Taking
the same data on a half-leaf basis, forming the ratios of
right half-leaf lesions to left half-leaf lesions for each of
240 leaves, gives 1.00 and 0.35 as the corresponding
values. The same CPSMV, SBMV, and TNV data were
analyzed by taking the ratio of the mean numbers of
lesions on each set of experimental leaves (or half-
leaves) to mean numbers for the corresponding set of
reference leaves (or half-leaves). The resulting standard
deviations for these ratios of means were 1.5- to 3-fold
greater than the standard deviations for the same data
expressed as the means of the ratios. Based on these
observations, for the assay results presented below, le-
sion counts are expressed as the mean of the ratios,
experimental leaf count divided by reference leaf count.
The concurrent protection effected by CPMV against
CPSMV in Arlington cowpea (Bruening et al., 1979;
Saayer-Riep and de Jager, 1988) previously was shown to
be retained by an F3 CPMV-resistant line derived from a
Blackeye 5 3 Arlington cross (Kiefer et al., 1984). Figure
1A shows a dose dependence for CPMV in its protection
against coinoculated CPSMV on the CPMV-resistant line
from the eighth backcross out of Blackeye 5 3 Arlington.
Protection was not observed when inoculation with the
two viruses was sequential (Fig. 1B). Concurrent protec-
tion showed a strong dose dependence when the CPMV
concentration was increased fourfold at a constant
CPSMV concentration (Fig. 1A, assays 3 and 2), whereas
there was little effect when CPMV and CPSMV were
increased in parallel fourfold (Fig. 1C, assays 14 and 10).
Concurrent protection mediated by CPMV B in CPMV-
resistant, but not in CPMV-susceptible, cowpea
We purified CPMV virion B, encapsidating RNA 1, and
virion M, encapsidating RNA 2. It is more difficult to purify
CPMV B than CPMV M to the point of being nearly free
of infectivity (Sterk and de Jager, 1987; Taliansky et al.,
1993). Purification of CPMV B by centrifugation in a mildly
alkaline CsCl gradient followed by centrifugation in a
nonionic medium gave CPMV B preparations that pro-
duced few lesions on CPMV-susceptible cowpea. To
bioassay the CPMV M and CPMV B preparations, we
inoculated the reference leaf with a mixture of 0.06 mg/ml
PMV B and 0.04 mg/ml CPMV M and the experimental
eaf with either 20 mg/ml CPMV M or 30 mg/ml CPMV B.
For the preparations used in the Fig. 2 experiments, the
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301ELICITOR IN CONCURRENT PROTECTIONreference and experimental leaves, each on a set of
eight plants, developed 44 6 14 and 2 6 1 lesions in the
ssay of CPMV M and 41 6 10 and 50 6 19 lesions in the
ssay of CPMV B. CPMV M did not protect CPMV-resis-
ant cowpea against coinoculated CPSMV (5 assays in 4
FIG. 1. Concurrent protection by CPMV against another Comovirus,
owpea severe mosaic virus (CPSMV) in CPMV-resistant cowpea. Sets of
ight seedlings (A–C) or four seedlings (D) were inoculated on a primary
eaf, designated as the experimental leaf, with protecting virus CPMV and
hallenging virus CPSMV. Virion concentrations are indicated by the ratio
resented above or within each bar, e.g., 16 mg/ml CPMV and 4 mg/ml
PSMV for assay 3. The opposite, reference primary leaf received the
ame concentration of CPSMV, alone. CPMV and CPSMV were coinocu-
ated except for two assays presented in (B). For assays 7 and 8, respec-
ively, CPMV was inoculated 13 min before or 13 min after CPSMV. For
A–C) and assays 15 and 17, lesions were counted. For each plant, the
esion number of the experimental leaf was divided by the lesion number
f the opposite, reference leaf to give a lesion number ratio. Each bar
ndicates the mean of the ratios of lesions and the standard deviation for
he leaf pairs. For assays 16 and 18, the leaves from assays 15 and 17,
espectively, were harvested at 6 days after inoculation and were ex-
racted. ELISA assessed the mass of accumulated CPSMV capsid per unit
eight of leaf tissue. The ratio of capsid mass, experimental leaf value
ivided by the reference leaf value, varied from 0.33 to 0.62 for assay 16
nd from 0.03 to 0.28 for assay 18. Each fraction on the line labeled “correl.”
s the Pearson correlation for the paired lesion numbers from the opposite
eaves for the eight-plant assays. P values were derived from a t test,
paired two samples for means. The P value corresponds to the probability
hat lesion numbers from paired opposite leaves could have been drawn
rom the same population. P values #0.05 are not given. For this and
ucceeding figures, each lettered panel presents results from a different
xperiment.xperiments, data not shown). As is shown by Fig. 2,
ssays 1, 3, 5, and 8, CPMV B alone was sufficient to
a
Frovide concurrent protection against CPSMV in the
PMV-resistant line.
When unfractionated virions were inoculated to CPMV-
usceptible cowpea, the bulk of the (chlorotic) CPMV-
nduced lesions appeared 1–2 days later than the bulk of
mainly necrotic) CPSMV-induced lesions. Nevertheless
e were unable to determine whether unfractionated
PMV protects CPMV-susceptible cowpea against coin-
culated CPSMV because of interference with CPSMV
esion counts by the earliest-appearing CPMV-induced
esions. The separated CPMV B preparations allowed us
o test whether concurrent protection could be observed
ith CPMV-susceptible cowpea as the host. CPMV B
reparations, inoculated alone for reference and coin-
culated with CPSMV, produced so few CPMV-induced
esions that the earlier appearing and more frequently
ecrotic CPSMV-induced lesions could be counted un-
quivocally. CPMV B did not protect CPMV-susceptible
owpea (Fig. 2, assays 7 and 9 compared with assays 5
nd 8, respectively) against coinoculated CPSMV.
Purified CPMV virion RNA was found to protect Arling-
on cowpeas against coinoculated CPSMV (Bruening et
l., 1979). However, we expected that transcripts of full-
ength CPMV RNA cDNA clones would not protect be-
ause of the delayed appearance of infection when tran-
cripts, rather than virion RNAs, are inoculated to sus-
eptible cowpea. In fact, infectious transcripts of CPMV
NA 1 cDNA clones, or transcripts of RNA 1 and RNA 2
lones combined, did not protect (data not shown).
PMV-mediated concurrent protection against two
on-Comoviruses
Results for the opposite-leaf assays of lesion numbers
n the CPMV-resistant line (Figs. 3 and 4) showed that
PMV-mediated concurrent protection acts against the
obemovirus SBMV and the Nepovirus Cherry leafroll
irus (CLRV). CLRV induced ;3-mm-diameter chlorotic
ingspots. However, these lesions, unlike those induced
y CPSMV, were unstable. The development of CLRV-
nduced lesions was monitored twice daily, and several
ounts were performed to capture the maximum number
f lesions on opposite leaves (Fig. 4) before those le-
ions faded. Sequential inoculation of CPMV and SBMV
Fig. 3, assays 3 and 14) or CLRV (data not shown)
esulted in no protection against the challenging virus.
CPMV B protected CPMV-resistant cowpea against
ot only CPSMV but also against SBMV (Fig. 3, assays 15
nd 16) and against CLRV (Fig. 4A). Challenging viruses
LRV, CPSMV, or SBMV were coinoculated with CPMV B
nd CPMV M in proportions typical of unfractionated
PMV. These inocula did not reduce the numbers of
hallenging virus-induced lesions more than coinocula-
ion of the challenging virus with CPMV B alone (Fig. 2,
ssays 2 vs 1, 4 vs 3, and 6 vs 5; Fig. 3, assay 16 vs 15;
ig. 4, assays 3 vs 2 and 6 vs 5). In 13 of 16 paired assays
CPMV
302 BRUENING ET AL.with CPSMV as the challenging virus, reduction in lesion
numbers was greater with CPMV B as protecting virus
than with combined CPMV B and CPMV M as protecting
virus. Similarly protection mediated by CPMV B was
greater than or equal to the protection from the combined
CPMV B and CPMV M, coinoculated with the challenging
virus, for seven of nine paired assays of SBMV and three
of three paired assays of CLRV (data not shown). These
FIG. 2. Concurrent protection against CPSMV effected by CPMV vir
except that the concentration ratios have three parts, representing the
All assays were on CPMV-resistant cowpea except assays 7 and 9 onresults suggest that CPMV M may partially counteract
the protective effect of CPMV B. However, we were not
a
f
a
b
v
F
CPMV B to CPMV M to SBMV in (D). In assays 3 and 14, CPMV was
inoculated 13 min before SBMV.able to discern a dose effect, i.e., consistently decreas-
ing protection, from adding increasing concentrations of
CPMV M to the mixture of CPMV B and challenging virus
(Figs. 2E and 3D). As is indicated above for CPSMV,
CPMV-induced lesions prevented assessing CPMV-me-
diated protection against SBMV or CLRV in CPMV-sus-
ceptible cowpea with unfractionated CPMV as the pro-
tecting virus. However, protection against SBMV was not
observed when CPMV B and SBMV were coinoculated to
CPMV-susceptible cowpea (Fig. 3, lanes 20–22), sug-
gesting that concurrent protection against SBMV did not
occur in CPMV-susceptible cowpea.
Concurrent protection effected a reduction in chal-
lenging virus titer as well as a reduction in numbers of
challenging virus-induced lesions. Opposite leaves were
inoculated as for lesion assays. ELISA assessed the
titers in leaf extracts. For both CPSMV (Fig. 1, assays 16
and 18) and CLRV (Fig. 4, assay 15), ELISA values, con-
verted to mass of capsid antigen, showed a reduction on
the experimental leaf relative to the reference leaf, when
the challenging virus was coinoculated with CPMV on
the experimental leaf. Eastwell and Kalmar (1997) dem-
onstrated a reduction in CPSMV titer in primary leaves of
Arlington cowpea when CPSMV was coinoculated with
CPMV.
As noted above for CPSMV, increasing the mass-
based concentration ratio of CPMV to SBMV or to
CLRV was more effective, for reducing the challenging
virus lesion numbers, than increasing CPMV and chal-
lenging virion concentrations at a constant ratio. Com-
pare Fig. 3 SBMV assays 2 vs 13 with assays 5 vs 9
nd assays 7 vs 11. The corresponding comparisons
or Fig. 4, CLRV, are assays 3 vs 6 with assays 8 vs 12
nd assays 10 vs 14. Thus we selected the mass-
ased concentration ratio of CPMV to challenging
cting as the protecting virus. Presentation of the data are as in Fig. 1
trations in the inoculum in mg/ml for CPMV B, CPMV M, and CPSMV.
-susceptible cowpea (cross-hatched bars).ion B a
concenFIG. 3. Concurrent protection against a cowpea strain of Southern
bean mosaic virus (SBMV) effected by CPMV on CPMV-resistant cow-
pea. The host for assays 1–19 was CPMV-resistant cowpea and for
assays 20–22 was CPMV-susceptible cowpea. See legend to Fig. 1 for
presentation conventions. Inoculum concentrations for the experimen-
tal leaf, in mg/ml, are presented as ratios, CPMV to SBMV in (A–C) andirion, in the inoculum, as the independent variable for
ig. 5.
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303ELICITOR IN CONCURRENT PROTECTIONRelative sensitivity of several viruses to CPMV-
mediated concurrent protection
Figure 5 provides a comparison of the relative sensi-
tivity of CLRV, CPSMV, and SBMV to CPMV-mediated
FIG. 4. Concurrent protection against Cherry leafroll virus (CLRV)
presentation conventions for lesion counts and ELISA. Inoculum conce
CPMV to CLRV in (B). Assays 14 and 15 were performed on the same i
ratio of capsid mass, determined by ELISA, experimental leaf value divid
FIG. 5. Relationship between degree of concurrent protection and
PMV:challenging virion concentration ratios for challenging viruses
LRV, CPSMV, and SBMV. The base-10 logarithm of the mean ratio of
esions, experimental leaf to reference leaf, was plotted on the ordi-
ate. The legend for Fig. 1 defines the mean ratio of lesions. The
quare root of the ratio of concentration, in the inoculum for the
xperimental leaf, protecting virus to challenging virus, was plotted on
he abscissa. CLRV, CPSMV, and SBMV data were derived, respec-
ively, from 5, 10, and 7 experiments with challenging virus concentra-
ion ranges of 2–16, 1–4, and 0.5–2.4 mg/ml. Each data point was
derived from lesion counts from eight plants. Each line is a least-
squares fit. We calculated, from the least-squares fit, the ratio of
protecting virus to challenging virus corresponding to a reduction in the
mean ratio of lesions to 0.5. The calculated ratios are 0.06 for CLRV, 0.9
for CPSMV, and 1.1 for SBMV. Additionally, a similar plot () and
calculation (ratio 5 2.8) are provided using a subset of the largest data
set from Fig. 2 of Wu and Rappaport (1961). These data of Wu and
Rappaport (1961) are from a single experiment with a fixed 0.5 mg/ml
concentration of the challenging virus Tobacco mosaic virus (TMV) U1.
The protecting virus was TMV U2, which was coinoculated with TMV
U1 to pinto bean (Phaseolus vulgaris). All of the plotted inoculum
concentration ratios are mass based, but the CPMV: SBMV ratios were
divided by 1.6 (particle weights of CPMV B and CPMV M virions
combined, divided by the particle weight of SBMV virions) to adjust for
the smaller particle weight of SBMV virions.concurrent protection on CPMV-resistant cowpea. The
ordinate for the Fig. 5 plot represents the logarithm of the
mean ratio of lesions. The abscissa represents the
square root of the ratio of protecting virion to challenging
virion concentrations in the inoculum. These axes were
selected empirically because they produced least-
square-fit lines of good fit nearly intersecting the origin.
Using the least-square-fit lines of Fig. 5, we estimated
the CPMV:challenging virus ratio that would reduce the
mean ratio of lesions to 0.5. According to these calcula-
tions, CLRV was ;20-fold more sensitive to CPMV-me-
diated concurrent protection than was SBMV, and SBMV
and CPSMV were similarly sensitive.
Two other challenging viruses, the Tombusvirus To-
mato bushy stunt virus (TBSV) and the Cucumovirus
Cucumber mosaic virus (CMV) were tested for their sen-
sitivity to concurrent protection in this system. Numbers
of CMV-induced lesions were insensitive to CPMV-me-
diated protection at the highest CPMV:CMV concentra-
tion ratio tested, 1000 mg/ml CPMV and 1 mg/ml CMV
data not shown). Lesion numbers on the experimental
nd reference leaves were not different at the P 5 0.05
FIG. 6. Effects of coinoculated CPMV on the lesion numbers induced
ed by CPMV on CPMV-resistant cowpea. See legend to Fig. 1 for
n ratios, in mg/ml, are for CPMV B to CPMV M to CLRV in (A) and for
ed primary leaves, harvested 8 days after inoculation. In assay 15, the
the reference leaf value, varied from 0.32 to 0.83 for the eight leaf pairs.effect
ntratioon CPMV-resistant cowpea by tomato bushy stunt virus (TBSV). See
legend to Fig. 1 for conventions.
b
w
304 BRUENING ET AL.level at a 64:1 CPMV:TBSV ratio in the inoculum but were
distinct at a 160:1 ratio (Fig. 6, assays 3 and 4). As
indicated by the calculation of the inoculum CPMV:chal-
lenging virus concentration ratio required to reduce the
mean ratio of lesions to 0.5 (Figs. 5 and 7), TBSV was
0.02 as sensitive as SBMV or CPSMV to CPMV-mediated
concurrent protection in CPMV-resistant cowpea.
As is reported above, CPMV virion B alone appears to
at least be as effective as a mixture of CPMV virions B
and M in effecting concurrent protection against CLRV
(Fig. 4A), CPSMV (Figs. 2A–2C), and SBMV (Fig. 3D).
CPMV B can be expected to induce only a “single-cell,” or
“subliminal,” infection; that is, an infection confined to the
inoculated cell (White and Antoniw, 1991). Sulzinski and
Zaitlin (1982) demonstrated that TMV induces subliminal
infections of inoculated cowpea primary leaves. We
tested the ability of TMV to protect against coinoculated
CPSMV. Only a limited reduction in CPSMV-induced le-
sions was observed over the concentration range of TMV
tested for both CPMV-resistant and -susceptible cowpea.
Results were similar to those observed for the weak
CPMV interference with TBSV-induced lesion formation
(Fig. 7).
DISCUSSION
CPMV-mediated concurrent protection compared to
cross protection and acquired resistance
FIG. 7. Comparison of CPMV and other potentially challenging vi-
ruses for their ability to reduce counts of lesions induced by several
coinoculated challenging viruses. Conventions are as for Fig. 5. The
lines for the least square fit to data of CPMV as protecting virus, and
CLRV, CPSMV, and SBMV as challenging viruses, are from Fig. 5 with
data points omitted. (F) CPMV as protecting virus and TBSV as chal-
lenging virus on CPMV-resistant cowpea. (E) TMV as protecting virus
and CPSMV as challenging virus, seven data points from CPMV-
resistant cowpea and three data points from CPMV-susceptible cow-
pea. Before plotting, and for reasons described in the legend to Fig. 5,
the mass-based concentration ratios for TMV: CPSMV were divided by
3.6 and for CPMV: TBSV were divided by 1.2. Data () for TMV U2 and
TMV U1 (Wu and Rappaport, 1961) coinoculated to pinto bean are the
complete set corresponding to the low-U2-concentration set of Fig. 5.Results from this laboratory (Bruening et al., 1979;
Bruening and Kiefer, 1981; Kiefer et al., 1984) first re-vealed the phenomenon that later was termed concur-
rent protection (Ponz and Bruening, 1986). These re-
searchers found that infectious CPMV genomic RNA,
encapsidated or unencapsidated, rather than CPMV cap-
sids or inactivated RNA, is needed to effect concurrent
protection. Saayer-Riep and de Jager (1988) presented
conclusions, but no lesion counts, from assays on pairs
of opposite primary leaves of Arlington and Tvu470 cow-
pea seedlings inoculated with 0.5–50 mg/ml of the To-
amovirus Sunnhemp mosaic virus (SHMV), with and
ithout 130 mg/ml CPMV. The mixed inocula resulted in
a reduction to no or a few SHMV-induced lesions. Similar
evidence for concurrent protection was presented for the
same concentration of CPMV and unknown concentra-
tions of the Potyvirus Blackeye cowpea mosaic virus and
CMV. Here we obtained evidence concerning the relative
sensitivity of five challenging viruses to CPMV-mediated
concurrent protection on seedlings from the CPMV-re-
sistant cowpea line derived from a Blackeye 5 3 Arling-
ton cross and subsequent backcross series. In order of
decreasing sensitivity to concurrent protection (Fig. 7
and data not shown), the challenging viruses are CLRV,
CPSMV, SBMV, TBSV, and CMV. The first three viruses
were substantially suppressed in terms of induced num-
bers of lesions when protecting virus CPMV was in-
cluded in the inoculum at less than five times the con-
centration of the challenging virus (Fig. 5). The CPMV-to-
challenging-virus ratio that would be required, for
reduction of lesion numbers by half, was more than an
order of magnitude greater for TBSV (Fig. 7), and for CMV,
than for three more affected challenging viruses. As is
discussed below, these quantitatively different results
may reflect qualitatively distinct mechanisms. CMV strain
differences may explain the apparent sensitivity of CMV
to concurrent protection in one and possibly two systems
(Sterk and de Jager, 1987; Kohm et al., 1993) but not in
experiments reported here.
Cross protection, acquired resistance, whether sys-
temic (SAR) or local (LAR), and concurrent protection all
require a protecting virus, a challenging virus, and spe-
cific host plant (Ponz and Bruening, 1986; Fraser, 1990,
1998; White and Antoniw, 1991; Sticher et al., 1997).
However, concurrent protection has important opera-
tional and functional distinctions from the other two phe-
nomena. Concurrent protection is induced without ap-
parent infection by the protecting CPMV. In contrast, a
systemic infection by the protecting virus mediates cross
protection, and SAR or LAR is induced after localized,
visible infection by the protecting virus. Concurrent pro-
tection, with CPMV-resistant cowpea as the host, was
not observed when the potential protecting virus CPMV
and the challenging virus were inoculated sequentially.
In contrast, systems showing cross protection or ac-
quired resistance require, or at least will tolerate, ad-
vance inoculation of the protecting virus. The most effec-
tive cross protection usually is induced by a protecting
s
c
n
p
305ELICITOR IN CONCURRENT PROTECTIONvirus or virus strain that is very similar to the challenging
virus or virus strain, whereas taxonomic similarity of
protecting CPMV and challenging virus does not seem to
be predictive of effective concurrent protection. This tax-
onomic indifference also applies to acquired resistance.
However, LAR or SAR clearly involves time-dependent
changes in cells surrounding the observable infection
site of the protecting virus or even throughout the plant.
If concurrent protection was a variant of LAR, for exam-
ple, the effect of the protecting virus would be expected
to increase with time after inoculation as the protecting
virus infection became established. Rather, in concurrent
protection, the protective effect disappears in minutes
after inoculation of the protecting virus with no apparent
change in the susceptibility of the plant to the challeng-
ing virus.
Possible general mechanism for concurrent
protection
We considered two broad categories of mechanisms
for reduction in lesion numbers observed after coinocu-
lation of challenging virus with CPMV: competition be-
tween CPMV and the challenging viruses and elicitation
by CPMV of a resistance response in CPMV-resistant
cowpea that acts against both CPMV and the challeng-
ing virus. As noted in Results, we observed a greater
reduction in lesion numbers when the CPMV:challenging
virus ratio in the inoculum was increased than when the
inoculum concentration was increased at a constant
CPMV:challenging virus ratio. This result supports a
competition hypothesis. However, most other evidence
supports an elicitor hypothesis.
Our results suggest critical events in concurrent pro-
tection occurring in the inoculated cell and an intimate
connection between resistance against CPMV and
CPMV-mediated concurrent protection. Bruening et al.
(1979) and Ponz and Bruening (1986) proposed that con-
current protection requires the presence of functional
virion RNA of both the protecting virus and the challeng-
ing virus in the inoculated cell. This supposition is based
on the observations that neither sequential inoculation
nor coinoculation of inactivated CPMV RNA with the
challenging virus resulted in concurrent protection. In
early general studies of the inoculation process, infec-
tion-susceptible sites were found to be lost if an interval
of only seconds or minutes elapsed between rubbing a
leaf with abrasive and applying virus inoculum (Jedlinski,
1956; Furomoto and Wildman, 1963). Transient suscepti-
bility provides indirect evidence for rapid healing of
wounds that presumably are sites for entry of virions.
Shackel et al. (1991) provide direct evidence for the rapid
ealing of controlled puncture wounds in and by plant
ells. That CPMV-induced concurrent protection is a phe-
omenon of the inoculated cell also is strongly sup-
orted by the effectiveness of CPMV B preparations inconcurrent protection against three viruses. Infections
initiated by CPMV RNA 1 presumably are limited to the
inoculated cell because the CPMV protein(s) required for
cell-to-cell movement and the coat proteins are encoded
on RNA 2 (Van Lent et al., 1990; Kasteel et al., 1993, 1997;
Wellink et al., 1993). The inability of the RNA 2-encapsi-
dating CPMV M to enhance concurrent protection, com-
pared to CPMV B alone, strongly suggests that no RNA 2
function is required for, or augments, concurrent protec-
tion.
We suppose that, if a sufficiently high concentration of
the protecting virus can be achieved in the inoculum, at
least a weak reduction in challenging virus-initiated in-
fection centers will be observed, assuming no synergis-
tic interaction between the two viruses. The observed
protection could be based, for example, on competition
between the two viruses rather than elicitation of a plant
response by the protecting virus. Competition against a
challenging virus, by CPMV as a potential protecting
virus, would be expected to be equally effective in CPMV-
resistant and -susceptible cowpea lines. Testing this
notion on CPMV-susceptible cowpea, for a virus such as
TBSV, would require obtaining large amounts of purified
CPMV B. However, another experiment shows that co-
inoculation of a challenging virus, with a potential pro-
tecting virus that induces only single-cell infections, is
not sufficient to initiate genotype-specific protection.
TMV coinoculated with CPSMV did not reduce the num-
ber of CPSMV-induced lesions on either CPMV-resistant
or -susceptible cowpea except at TMV:CPSMV ratios
comparable to the high CPMV:TBSV ratios needed to
give a small reduction in TBSV-induced lesions on
CPMV-resistant cowpea (Fig. 7). We believe that the
protecting virus, infecting the single cell, must be recog-
nized specifically in that cell to induce concurrent pro-
tection and that the recognition mechanism is involved in
the robust, Arlington-derived resistance against CPMV.
Thus we regard CPMV-mediated concurrent protection
to be CPMV elicitor-mediated and effective against
CLRV, CPSMV, and SBMV but not against TBSV or CMV.
How TBSV and CMV avoid concurrent protection in our
system is unknown but may be related to the relative
speed with which the various challenging viruses estab-
lish infections relative to the timing for initiation of a
CPMV-activated defense system in CPMV-resistant cow-
pea.
We contend that concurrent protection principally is a
phenomenon of the inoculated cell and reflects plant
response to the action of viable CPMV in that cell. Given
the concentrations of protecting and challenging virions
in the inoculum, it is likely that any cell receiving chal-
lenging virus also receives protecting virus. Few lesions
should form simply because challenging virus reached a
cell that received less than an infectious dose of protect-
ing virus. Rather the number of challenging virus-initiated
lesions probably reflects the number of coinoculated
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306 BRUENING ET AL.cells in which the challenging virus eluded containment
by CPMV-initiated events and was able to establish a
lesion-generating infection. Concurrent protection
against CPSMV and CLRV was documented by ELISA of
extracts of the inoculated primary leaves of CPMV-resis-
tant cowpea as well as by lesion counts (Figs. 1D and
4B), showing that not just lesion development is affected
by coinoculated CPMV. Results from ELISA of challeng-
ing virus capsid antigen are dependent on the conditions
under which the plants are cultured and the time that has
elapsed for virus to increase between inoculation and
preparation of extracts. Interpretation of ELISA results
necessarily is clouded by lack of information that can
connect increased virion titer to the numbers of initially
infected centers. Hence ELISA results, though useful,
will be less informative than lesion counts about the
numbers of cells initially infected and about the degree
of protection achieved.
Other systems possibly exhibiting concurrent
protection
Wu and Rappaport (1961) described a system of two
TMV strains, U1 and U2, and pinto bean as host. U2
TMV causes no visible symptoms on primary leaves of
pinto bean. However, U2 TMV coinoculated with U1
TMV reduced the number of U1 TMV-induced lesions.
We transformed and plotted in Figs. 5 and 7 data of Wu
and Rappaport (1961) on the U2 TMV concentration
dependence for suppression of U1 TMV lesion num-
bers. The result is not unlike that seen for CPMV
coinoculated with SBMV or CPSMV, at least in the
lower U2 TMV concentration range (Fig. 5). Conceiv-
ably, U2 TMV may be the protecting virus and U1 TMV
the challenging virus in a non-CPMV example of con-
current protection.
The well-characterized potato gene Rx (Bendah-
ane et al., 1999) confers extreme resistance against
he Potexvirus Potato virus X (PVX). PVX-inoculated,
x-bearing potato develops no symptoms, and proto-
lasts from such plants are highly resistant to PVX.
esistance-breaking strains of PVX have been ob-
ained, and substitution of a single amino acid residue
n the PVX coat protein is sufficient to confer the
esistance-breaking character (Goulden et al., 1993).
ohm et al. (1993) coinoculated protoplasts from Rx-
earing potato with either a resistance-breaking PVX
train or CMV as the challenging virus and a resis-
ance-sensitive PVX strain as the protecting virus. The
esult was greatly reduced accumulation of the chal-
enging virus RNAs, consistent with the coat protein of
esistance-sensitive PVX acting as an elicitor. Under
his hypothesis, the PVX-encoded elicitor activated a
echanism that was effective against not only the
liciting virus but also against the other coinoculated
iruses. The activation of resistance against PVX did
1
tot result in any apparent increase in protoplast death
nd proceeded in the presence of the transcription
nhibitor actinomycin D (Kohm et al., 1993; Gilbert et
l., 1998).
onnections of concurrent protection to cowpea
esistance against CPMV
Concurrent protection and resistance against CPMV
re connected by cowpea genetics and by results from
oinoculation of challenging virus with CPMV B. Selec-
ion was for resistance against CPMV only, in an eight-
eneration backcross series. Nevertheless the resulting
esistant cowpea line showed concurrent protection,
uggesting that the same or closely linked genes control
oth resistance against CPMV and CPMV-mediated con-
urrent protection. Inoculating CPMV B as the protecting
irus was intended to provide comparable, presumably
ingle-cell, infections in both CPMV-resistant and -sus-
eptible cowpea. Our results in Fig. 2, assays 9 vs 8 and
vs 5 and in Fig. 3, assays 20, 21, and 22 vs 15, are
onsistent with concurrent protection in the CPMV-resis-
ant line but not in the nearly isogenic, CPMV-susceptible
ine. Sterk and de Jager (1987) and Eastwell and Kalmar
1997) showed that partially purified preparations of
PMV B can mediate concurrent protection against
PSMV in CPMV-resistant cowpea. However, neither
roup reported inoculations of CPMV-susceptible cow-
ea with CPMV B and CPSMV or other challenging virus.
his test requires highly purified CPMV B. Eastwell and
almar (1997) do not provide analysis of the purity of their
PMV B preparation(s). Sterk and de Jager (1987) report
hat their CPMV B preparations were 1/40 to 1/20 as
nfectious without added CPMV M compared to the same
reparation with CPMV M added. The preparations of
PMV B used here to inoculate CPMV-susceptible cow-
ea were ;1/500 as infectious when inoculated alone as
hen coinoculated with CPMV M.
Other observations bear on whether CPMV-mediated
oncurrent protection is characteristic only of CPMV-
esistant cowpea. Bruening et al. (1979) investigated the
ffect of coinoculating CPMV and CPSMV to the cowpea
ocal lesion host Chinese red 3 Iron, whose seedlings
evelop very small, necrotic lesions when inoculated
ith CPMV and uniformly much larger, chlorotic lesions
hen inoculated with CPSMV. Numbers of CPSMV-in-
uced lesion were not reduced, relative to inoculation of
PSMV alone, when the CPSMV was coinoculated with
PMV. This result is consistent with a requirement for a
PMV-resistant host in demonstrating concurrent pro-
ection. Eastwell and Kalmar (1997) obtained a result
ossibly supportive of concurrent protection in CPMV-
usceptible cowpea. They found a significant reduction
nd delay in CPSMV capsid antigen accumulation when
.2 mg/ml CPSMV was coinoculated with 40 mg/ml CPMV
o a CPMV-susceptible line compared to inoculation of
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307ELICITOR IN CONCURRENT PROTECTIONCPSMV alone. It is possible that, at this high ratio of
CPMV to CPSMV in the inoculum, the observed reduc-
tion in CPSMV accumulation was not due to concurrent
protection. Cross protection or other interference phe-
nomenon between CPMV and CPSMV could prevail un-
der circumstances where both viruses can replicate and
spread in the inoculated leaf. Eastwell and Kalmar (1997)
do not report the results of sequential inoculation of
CPMV and CPSMV in this system.
Ponz et al. (1988) obtained similar fractions enriched in
low molecular weight proteins from leaf extracts of
Blackeye 5 cowpea, Arlington cowpea, and a CPMV-
resistant cowpea line from the seventh backcross in the
eight-backcross series that generated the CPMV-resis-
tant cowpea line used here. Similar dilutions of the frac-
tions from the two CPMV-resistant lines, but not the
diluted extract from Blackeye 5, appeared to interfere
with the in vitro processing of the CPMV RNA 2 polypro-
tein as catalyzed by in vitro translation products of CPMV
RNA 1. Thus the fraction from CPMV-resistant cowpea
appeared to contain a candidate CPMV-resistance fac-
tor, possibly a protease-inhibitor, encoded in the Arling-
ton-derived dominant locus for resistance against CPMV.
As reported here, our results suggest that this same
Arlington-derived locus encodes a gene that recognizes,
directly or indirectly, a CPMV RNA-1-encoded elicitor.
The genes for the protease inhibitor and for an elicitor-
recognizing protein may be closely linked in the CPMV-
resistance locus or there may be a single gene for the
two activities. If there are two genes, the presumed
protease inhibitor may be relevant or irrelevant to the
observed resistance against CPMV. If the protease in-
hibitor and the elicitor-recognizing protein are the same
molecule, that molecule may be endowed with the ability
to bind to the CPMV RNA 1 polyprotein or one or more of
its processing products, eliciting a response that medi-
ates resistance and concurrent protection and interfering
with polyprotein processing.
MATERIALS AND METHODS
Virion preparations
CLRV was purified according to Brooks and Bruening
(1995) and was a gift from Dr. Mindy Brooks. CMV inoc-
ulum was a California isolate. CMV virions were purified
from inoculated small sugar pumpkin (Cucurbita pepo)
essentially as described by (Roossinck and White, 1998).
CPMV inocula for virion preparations were extracts of a
Blackeye 5 cowpea that had been inoculated with two
plasmids (Dessens and Lomonossoff, 1993) bearing full-
length copies of RNA 1 and of RNA 2. CPMV and CPSMV
were purified from Blackeye 5 cowpea (Bruening, 1969).
SBMV from cowpea and TBSV from Nicotiana benthami-
ana both were purified by modifications of TBSV purifi-
cation methods (Gallitelli et al., 1985; Burgyan and Russo,
1998). Grinding buffer for SBMV was 0.2 M sodium ace-tate, 0.075 M acetic acid, pH 5.0, and suspension buffer
was grinding buffer diluted to 50 mM sodium acetate. For
TBSV, grinding and suspension buffers were, respec-
tively, 0.2 M sodium acetate and 0.11 M acetic acid and
50 mM sodium acetate and 9 mM acetic acid. TMV was
purified from N. tabacum (Mandeles and Bruening, 1968).
CsCl gradients for separation of CPMV virions were
prepared in Beckman SW41-Ti swinging bucket rotor
tubes by layering 3 ml each of 0.39, 0.35, and 0.31 g/g of
CsCl solutions followed by brief stirring with a small-
diameter glass rod. CsCl gradient buffers were 50 mM
KH2PO4, 10 mM K2HPO4 (pH ;6) or 55 mM sodium Tris
ydroxymethylmethylamino-propane sulfonic acid (TAPS,
igma Chemical Co.), 45 mM TAPS-free acid (Sigma),
nd 5 mM Na2EDTA (pH ;8.4). Centrifugation was for
12–14 h at 35,000 rpm and 5°C. Nycodenz (Sigma) gra-
dients were prepared as described (Taylor et al., 1999) in
7.5 mM K2HPO4 and 5 mM KH2PO4. Centrifugation was
or 15–19 h at 36,000 rpm and 15°C. Polyacrylamide
eads (BioRad BioGel P10) were added to all gradients
s a density marker (Bruening, 1969). Recovery of CPMV
was after two cycles of CsCl centrifugation at pH 6 and
ne cycle of Nycodenz centrifugation. CPMV B was re-
overed as component BU after CsCl centrifugation at pH
6, then as BL after CsCl centrifugation at pH 8.4 and,
inally, Nycodenz centrifugation. Virion densities are
iven by Bruening (1969). Virion concentrations were
etermined using a260 (cm
2mg21) of 10 for CLRV (Rowhani
et al., 1985), 5.0 for cucumber mosaic virus (Roossinck
and White, 1998), 6.2 for CPMV M, 10.0 for CPMV B, 8 for
unfractionated CPMV (de Jager, 1976), 5.85 for SBMV
(Shepherd, 1971), 4.5 for TBSV (Martelli et al., 1971), and
2.7 for TMV (Mandeles and Bruening, 1968).
Cowpea lines and assays
Sources of CPMV-susceptible cowpea line Blackeye 5
and cowpea-resistant line Arlington are as described
(Beier et al., 1977). A cowpea cross of cultivar Blackeye
5 3 Arlington was the source of an F3 line homozygous
for resistance against CPMV (Kiefer et al., 1984). A cross
of Blackeye 5 with this F3 line began a backcross series,
with Blackeye 5 as the recurrent parent, that was con-
tinued through an eighth backcross, selecting only for
resistance against CPMV. The nearly isogenic lines were
homozygous CPMV-resistant line 9405CII and homozy-
gous CPMV-susceptible line 9405Gii, as F4 derivatives
from the progeny of the eighth backcross.
Opposite leaf assays were on 5- to 8-day-old cowpea
seedlings with primary leaves almost fully expanded and
trifoliate leaves ,0.5 cm long. Unless indicated other-
wise, eight seedlings were inoculated for each assay.
Inoculation buffer was 30 mM K2HPO4, 20 mM KH2PO4,
nd 1 mM Na2EDTA, and the abrasive was carborundum.
For sequential inoculations, the reference leaf was
rubbed with buffer at time 0 and with an inoculum of
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308 BRUENING ET AL.challenging virions at 13 min. After the first inoculation,
the leaves were rinsed with water, carefully dried with
laboratory paper tissue, and dusted again with carborun-
dum. The experimental leaf was treated similarly except
that CPMV virions were inoculated at time 0 and chal-
lenging virions were inoculated at 13 min. A control in
these experiments was cowpea seedlings rubbed with
buffer only at time 0 and with challenging virions (refer-
ence leaf) or challenging virions and CPMV virions (ex-
perimental leaf) at 13 min.
Direct ELISA (Rowhani et al., 1985) was used to as-
ess mass of accumulated CLRV or CPSMV capsids per
nit fresh weight of inoculated primary cowpea leaf, by
omparison with reference virion preparations. CLRV
nd CPSMV virions were purified from single, inoculated
rimary leaves by small-scale versions of standard pro-
edures (Bruening, 1969; Rowhani et al., 1985; Brooks
nd Bruening, 1995). Rabbit anti-CLRV IgG was a gift
rom A. Rowhani. Rabbit anti-CPSMV IgG was prepared
y chromatography of antiserum to purified virions on a
rotein A column. ELISA plate were loaded with dilutions
f single-leaf virion preparations and reference virion
olution. Detection was with rabbit IgG preparations and
oat anti-rabbit immunoglobulin conjugated to alkaline
hosphatase (BioRad).
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